In The News: School of Integrated Health Sciences

Philanthropy News Digest

The University of Nevada, Las Vegas has announced a $6 million commitment from Joy Chambers-Grundy and the late Reg Grundy to establish a center dedicated to research on and the treatment of neurological disorders.

Philanthropy News Digest

The University of Nevada, Las Vegas has announced a $6 million commitment from Joy Chambers-Grundy and the late Reg Grundy to establish a center dedicated to research on and the treatment of neurological disorders.

Las Vegas Review Journal

UNLV announced Monday that it has launched a center dedicated to scientific research about brain and neurological diseases such as Alzheimer’s and dementia.

Las Vegas Review Journal

UNLV announced Monday that it has launched a center dedicated to scientific research about brain and neurological diseases such as Alzheimer’s and dementia.

Newswise

The UNLV department of brain health has formally launched the Chambers-Grundy Center for Transformative Neuroscience, offering hope through scientific discovery for patients who are suffering from Alzheimer’s, dementia and other brain and neurological diseases.

Newswise

The UNLV department of brain health has formally launched the Chambers-Grundy Center for Transformative Neuroscience, offering hope through scientific discovery for patients who are suffering from Alzheimer’s, dementia and other brain and neurological diseases.

Newswise

The UNLV department of brain health has formally launched the Chambers-Grundy Center for Transformative Neuroscience, offering hope through scientific discovery for patients who are suffering from Alzheimer’s, dementia and other brain and neurological diseases.

Sweety High

We've always found the idea of vitamins that aid in hair, nail and skin health to be super appealing.

Tall Architects

Here are some of our favourite articles from April.

Human Resources Director

Skip the fancy furniture! Here are simple hacks following principles of ergonomics

Yahoo!

An experimental drug could help caregivers as well as patients, as it substantially improved agitation in Alzheimer's patients in a late-stage clinical trial. The announcement boosted the shares of the maker of the treatment, Axsome Therapeutics (AXSM), nearly 25% to more than $95.

Gear Patrol

The author of a brand-new sports training book delves into the game-changing concept of “external focus.”